ARECOR THERAPEUTICS PLC (AREC) — Final Results Results for the year ended 31 December 2024

Investor webinar replay

Replay transcript excerpt

Good afternoon, ladies and gentlemen, and welcome to the ARECOR THERAPUITIX PLC Investor Presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged. They can be submitted at any time via the Q and A tab that's just situated on the right hand corner of your screen. Please just simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all questions submitted today and we'll publish those responses where it's appropriate to do so on the Investor Meet company platform. And before we begin, we would just like to submit the following poll. And if you could give that your kind attention, I'm sure the company would be most grateful. And I would now like to hand you over to the executive management team from ARECOR THERAPUITIX PLC. Sarah, good afternoon. Good afternoon. Thank you. And so good afternoon, everybody. Thank you for taking the time to join us today. And as you know, my name is doctor Sarah Howell. I'm the CEO of ARECOR THERAPUITIX, and I'm joined today, by with David Ellum, who's our chief financial officer. So today, we're going to talk you through our results and for the year ending the 12/31/2024. So I'll draw your attention to our customary legal notice. So I think probably most people on the the line today, I'm sure I will have spoken to previously and you would have heard me present, but I'd like to just take the opportunity to allow David to introduce himself. Many of you may have seen that David joined us as interim CFO back in November of last year. I'm very pleased to confirm he's now joined us permanently as our chief financial officer. So, David, if I could just hand over to y...